Accumulating evidence suggests that ASK1 may contribute to the pathogenesis of AD and other neurodegenerative disorders by regulating various cellular responses such as apoptosis, cell survival, and differentiation (Song et al., 2014). This evidence concerns the gene MAP3K5 and Alzheimer disease.